NovaBridge Biosciences (NBP) Insider Trading

Over the last 3 months, NBP insiders made 0 open-market buys and 2 sales, a net sale of -$10K (SEC Form 4).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
2
Net (3m)
-$9.6K
Insider trades by month Buys Sells
Apr
May
Jun
Jul
Context3-month price +7.6%
DateInsiderTypeSharesPrice
Aug 25, 2026Lenz Robert A.directorOption7,486—
Aug 25, 2026Lenz Robert A.directorOption17,218—
Jul 10, 2026Hagler Mark Arnoldofficer: Chief Commercial OfficerGrant949,050$1.93
Jul 10, 2026Lin Liwei Lorraineofficer: General CounselGrant254,780$1.93
Jul 8, 2026Gupta Srishtidirector, officer: Chief Executive OfficerGrant3,000,000$2.01
Jul 7, 2026Xu Cong Claireofficer: SVP, Clinical DevelopmentOption5,405—
Jul 7, 2026Xu Cong Claireofficer: SVP, Clinical DevelopmentSell4,485$0.89
Jul 7, 2026Xu Cong Claireofficer: SVP, Clinical DevelopmentOption12,432—
Jun 30, 2026Fu WeidirectorGrant725,140$2.45
Jun 30, 2026Fu WeidirectorGrant1,087,720$2.45
Jun 30, 2026Fu WeidirectorGrant1,010,100—
Jun 24, 2026Cao Sean Wuxiongdirector, officer: Chief Bus. Development OfficerGrant181,290$1.53
Jun 24, 2026Cao Sean Wuxiongdirector, officer: Chief Bus. Development OfficerGrant181,280—
Jun 22, 2026Dennis Phillip Andrewofficer: Chief Medical OfficerOption23,695—
Jun 22, 2026Dennis Phillip Andrewofficer: Chief Medical OfficerOption10,302—
Jun 22, 2026Dennis Phillip Andrewofficer: Chief Medical OfficerSell8,494$0.66
Jun 2, 2026Xu Cong Claireofficer: SVP, Clinical DevelopmentOption4,079—
Jun 2, 2026Xu Cong Claireofficer: SVP, Clinical DevelopmentSell3,494$3.94
Jun 2, 2026Xu Cong Claireofficer: SVP, Clinical DevelopmentOption9,382—
May 18, 2026Cao Sean Wuxiongdirector, officer: See RemarksSell21,399$1.99
Apr 28, 2026Hagler Mark Arnoldofficer: See RemarksBuy230,000$2.51

Source: NBP SEC Form 4 filings, latest Aug 25, 2026. For informational purposes only — not investment advice.

← Back to NBP overview (price, financials, earnings)